3 Stocks Underperforming Today In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.3%) at 16,357 as of Wednesday, Jan. 22, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,698 issues advancing vs. 1,213 declining with 185 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Boston Scientific ( BSX), down 1.0%, Medtronic ( MDT), down 0.8% and WellPoint ( WLP), down 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Hologic ( HOLX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Hologic is down $0.79 (-3.5%) to $21.49 on average volume. Thus far, 1.9 million shares of Hologic exchanged hands as compared to its average daily volume of 4.3 million shares. The stock has ranged in price between $21.29-$21.99 after having opened the day at $21.99 as compared to the previous trading day's close of $22.28.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. Hologic has a market cap of $6.2 billion and is part of the health care sector. Shares are up 1.0% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Hologic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Cigna ( CI) is down $0.55 (-0.6%) to $89.58 on light volume. Thus far, 288,265 shares of Cigna exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $89.29-$90.48 after having opened the day at $90.35 as compared to the previous trading day's close of $90.13.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $24.7 billion and is part of the health care sector. The company has a P/E ratio of 13.6, below the S&P 500 P/E ratio of 17.7. Shares are up 3.0% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, St Jude Medical ( STJ) is down $0.87 (-1.3%) to $65.09 on heavy volume. Thus far, 2.1 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $63.85-$66.10 after having opened the day at $66.00 as compared to the previous trading day's close of $65.96.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $19.2 billion and is part of the health care sector. The company has a P/E ratio of 26.7, above the S&P 500 P/E ratio of 17.7. Shares are up 6.5% year-to-date as of the close of trading on Tuesday. Currently there are 11 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Bring On the Bitcoin Futures Trading Insanity!

Bring On the Bitcoin Futures Trading Insanity!

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These Stocks Have Changed Direction

These Stocks Have Changed Direction

How to Buy Great, Cheap Stocks When Indexes Are at All-Time Highs

How to Buy Great, Cheap Stocks When Indexes Are at All-Time Highs

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course